CBA/J mice infected with Trypanosoma cruzi: An experimental model for inflammatory myopathies

Muscle and Nerve

Volumn 27, Issue 4, 2003, Pages 442-448

  Andersson, John ^a   Englund, Pernilla ^b   Sunnemark, Dan ^c   Dahlstedt, Anders ^b   Westerblad, Håkan ^b   Nennesmo, Inger ^d   Örn, Anders ^a   Lundberg, Ingrid E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Animal model; Inflammatory myopathy; Myositis; Trypanosoma cruzi

Indexed keywords

CD8 ANTIGEN;

ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; FEMALE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY INFILTRATE; MACROPHAGE; MOUSE; MOUSE STRAIN; MUSCLE CELL; MUSCLE DISEASE; MUSCLE NECROSIS; MUSCLE WEAKNESS; MYOPATHY; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

ANIMALS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICE, INBRED CBA; MUSCLE FIBERS; MUSCLE, SKELETAL; MYELITIS; TRYPANOSOMA CRUZI;

EID: 0344407453     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10338     Document Type: Article

References (19)

1. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
2. Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Hoger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet 1999;23:141-142.
3. Brandariz S, Schijman A, Vigliano C, Arteman P, Viotti R, Beldjord C, Levin MJ. Detection of parasite DNA in Chagas' heart disease. Lancet 1995;346:1370-1371.
4. Buckner FS, Van Voorhis WC. Immune response to Trypanosoma cruzi: control of infection and pathogenesis of Chagas disease. In: Cunningham MW, Fujinami RS, editors. Effects of microbes on the immune system. Philadelphia: Lippincott Williams & Wilkins; 2000. p 569-591.
5. Buckner FS, Wilson AJ, Van Voorhis WC. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun 1999;67:403-409.
6. Cossermelli W, Friedman H, Pastor EH, Nobre MR, Manzione A, Camargo ME, Shiroma M. Polymyositis in Chagas's disease. Ann Rheum Dis 1978;37:277-280.
7. Cunnane G, Bjork L, Ulfgren AK, Lindblad S, FitzGerald O, Bresnihan B, Andersson U. Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements. Ann Rheum Dis 1999;58:493-499.
8. Dalakas MC. Current treatment of the inflammatory myopathies. Curr Opin Rheumatol 1994;6:595-601.
9. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995;37:S74-S86.
10. Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986;17:704-721.
11. Gherardi RK. Skeletal muscle involvement in HIV-infected patients. Neuropathol Appl Neurobiol 1994;20:232-237.
12. Klareskog L, McDevitt H. Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions. Curr Opin Immunol 1999;11:657-662.
13. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R, Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P. From the cover: conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci USA 2000;97:9209-9214.
14. Pickering MC, Walport MJ. Eosinophilic myopathic syndromes. Curr Opin Rheumatol 1998;10:504-510.
15. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715-724.
16. Rosenberg NL. Experimental models of inflammatory myopathies. Baillieres Clin Neurol 1993;2:693-715.
17. Sunnemark D, Ulfgren A-K, Örn A, Harris RA. Cytokine production in hearts of Trypanosoma cruzi infected CBA mice - do patterns in the chronic stage reflect establishment of myocardial pathology? Scand J Immunol 1996;44:421-429.
18. Weller AH, Magliato SA, Bell KP, Rosenberg NL. Spontaneous myopathy in the SJL/J mouse: pathology and strength loss. Muscle Nerve 1997;20:72-82.
19. Ytterberg SR. The relationship of infectious agents to inflammatory myositis. Rheum Dis Clin North Am 1994;20:995-1015.